3rd Annual Executing Global Clinical Trials Conference, 13-14 September 2012, Boston, MA

3rd Annual Executing Global Clinical Trials Conference, 13-14 September 2012, Boston, MA

Main Category: Conferences
Article Date: 27 Jun 2012 - 7:00 PDT

email to a friend   printer friendly   opinions   <!-- rate article
Patient / Public:

Healthcare Prof:

5 (12 votes)

The Conference Forum has announced that the 3rd Annual Executing Global Clinical Trial's event will take place on September 13-14 at the Fairmont Copley Square Hotel in Boston, MA. "The trend to globalization creates opportunities and challenges for clinical trial management. To be successful, we must focus on quality, ethics, fair market value, logistics and culture," says Dr Barbara Skinn, Director of Collaborative Science Center of Excellence at Bristol-Myers Squibb.

Led by Dr Skinn along with Dr Mitchell Katz, Executive Director Medical Research Operations at Purdue Pharma and Dr Aleksander Skuban, Director, Clinical RD Emerging Markets at Merck, the conference addresses the most critical issues in globalizing complex studies to make significant progress to advance drug development for the benefit of patients globally.

Dr Debra S. Barker, Chief Scientific Officer, Emerging Markets, Novartis and Dr Christopher Gallen, CEO, SK Bio-Pharmaceuticals are delivering the keynote addresses. David R. Jones, Expert Scientific Assessor (Pharmacotoxicologist), Licensing Division, Medicines and Healthcare Products Regulatory Agency (MHRA), UK is a featured presenter speaking on How to Do Clinical Trials in Europe: Clarifying Confusion, Changes Updates.

As part of the conference, attendees will participate in region-specific round table discussions, including one-on-one question time with an industry expert in the following countries:

• China
• EU
• Latin America
• India
• Russia/Ukraine
• Canada
• Brazil
• Eastern Europe
• Australia
• Korea

Valerie Bowling, the Conference Director, commented, "Global clinical trial leaders universally requested we address the issues with the entire scope in mind to cover regulations, country-specific feasibility, infrastructure, training, support, diversity of locations, patients and culture, and we have developed the event specifically to do so."

Participating companies include: Novartis; BBK Worldwide; CSL Behring; Endo; Strategic Clinical Research Consulting, LLC; Baxter Healthcare Corporation; SK Bio- Pharmaceuticals; Millenium Pharmaceuticals; Momenta Pharmaceuticals; Medicines and Healthcare Products Regulatory Agency (MHRA), UK; Purdue Pharma LP; EnVivo Pharmaceuticals, Inc; Target Health; AMAG Pharmaceuticals; Merck Brazil; Merck Research Laboratories; Bristol-Myers Squibb; AAHRPP; Marken and Zalicus.

For more information, please visit http://www.theconferenceforum.org

CONTACT: CIARA HEALY
PHONE: 646 350 2580 X310
EMAIL:Chealy@theconferenceforum.org

• Additional
• References
• Citations

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

---

APA

---

Please note: If no author information is provided, the source is cited instead.

---

Add Your Opinion On This Article

'3rd Annual Executing Global Clinical Trials Conference, 13-14 September 2012, Boston, MA'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

back to top | home | privacy policy

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.